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substance classes, a smaller effect for cannabis-related disorder when compared to other SUDs was found
with regard to the IGT. Early onset of substance use and psychiatric comorbidities were associated with
stronger effects on the DD. Our findings suggest that feedback processing is more vulnerable to specific
substance effects, while valuation of delayed gratification depends more on developmental and clinical
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Across numerous studies, individuals with substance use disorders (SUDs) differed from non-
using controls regarding valuation of delayed gratification and feedback processing. However, 
it remains unclear whether the magnitude of the effect sizes is different across these two 
cognitive processes and how specific SUDs as well as demographic and clinical moderators 
influence these effects. In this study we thus performed multilevel linear mixed-effects meta-
analyses and meta-regressions to examine the effects of SUDs on the Delay Discounting Task 
(DD) and on the Iowa Gambling Task (IGT). We found a moderate to large effect for SUD on 
both, the IGT and DD. While the effect on the DD was generalized to all substance classes, a 
smaller effect for cannabis-related disorder when compared to other SUDs was found with 
regard to the IGT. Early onset of substance use and psychiatric comorbidities were associated 
with stronger effects on the DD. Our findings suggest that feedback processing is more 
vulnerable to specific substance effects, while valuation of delayed gratification depends more 
on developmental and clinical factors. 
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Substance use disorders (SUDs) are chronic psychiatric conditions that comprise a 
cluster of cognitive, behavioural and physiological symptoms indicating that the individual 
continues using a substance despite significant substance-related problems (APA., 2013). The 
diagnosis of a substance use disorder is based on a pathological pattern of behaviours, which 
often involve shifting from an impulsive initial drug use to a compulsive drug-seeking 
behaviour and loss of control over limited drug intake (Volkow and Morales, 2015). An 
increasing amount of research has associated decision-making impairments with addiction, 
leading to proposals that impairments in this function could play a role in the aetiology – but 
also occur as consequence – of SUDs, thereby contributing to both the initiation and 
maintenance of addictive behaviour (Bickel et al., 2018; Koffarnus and Kaplan, 2018). 
Decision-making reflects the ability to choose the most advantageous option from a range of 
alternatives, considering both their short-term and long-term consequences (Bechara, 2005). It 
involves a series of different processes that has been summarized e.g., in the three-stage 
framework proposed by Verdejo-Garcia et. al. (2018) and the neurobiological framework of 
value-based decision-making proposed by Rangel et al. (2008). Despite some conceptual 
differences, it is well-accepted that two key processes involved in decision-making are the 
choice implementation or action selection, and the feedback processing or outcome evaluation 
(Rangel et al., 2008; Verdejo-Garcia et al., 2018). Remarkably, it has been shown that 
substance-dependent individuals differ from drug-naive controls regarding their valuation of 
delayed rewards during choice implementation and their learning from feedback processing 
(Verdejo-Garcia et al., 2018).  
With regard to choice implementation, people with SUDs tend to evaluate delayed 
rewards as less worth than immediate rewards, showing a clear preference for smaller 
immediate rewards over a larger delayed reward – known as the temporal discounting effect 
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(Amlung et al., 2017; Biernacki et al., 2016; MacKillop et al., 2011). Concerning feedback 
processing, SUDs are associated with difficulties in terms of learning from punishment or the 
history of reinforcement, resulting in worse performance on tasks where they are required to 
incorporate prediction errors to optimally guide future behaviour (Biernacki et al., 2016; 
Kovacs et al., 2017).  
Such impairments display correspondence with clinical outcomes, given that people 
with SUDs often forgo occupational or recreational activities in order to use drugs. Such self-
defeating behaviours might indicate that, as the immediate rewards associated with drugs 
increase in subjective value, the delayed rewards associated with ordinary life events decrease 
in subjective value (Bickel and Marsch, 2001) – however, based on a means-end analysis it 
was recently suggested that self-defeating behaviours can also demonstrate the “hallmarks of 
goal pursuit” (Kopetz and Orehek, 2015). Additionally, people with SUDs habitually keep 
using drugs despite the short- and long-term negative consequences associated with this 
behaviour, such as financial costs (Vonmoos et al., 2018), increases in psychiatric symptoms 
(Cunha et al., 2011), cognitive impairments (Hulka et al., 2014; Vonmoos et al., 2014), and 
social dysfunction (Preller et al., 2014a; Preller et al., 2014b). Importantly, although the Delay 
Discounting paradigms (DD) and the Iowa Gambling Task (IGT) are not representative for 
the entire field of decision-making, they are two of the most established behavioural tasks for 
assessing different facets of decision-making in the addiction field, being used to mainly 
investigate, but not exclusively, valuation of delayed rewards during choice implementation 
and feedback processing (Verdejo-Garcia et al., 2018), respectively. The wealth of recent 
literature produced with these two tasks raises an opportunity to generate estimates across 





1.1 The Delay Discounting 
DD paradigms were initially introduced in the behavioural economics field following 
the observation that the value of a delayed reward is discounted when compared to the value 
of an immediate reward (for a review see Bickel, et al. 2001). In this paradigm, participants 
are usually requested to choose between a small immediate monetary reward and a large 
delayed reward, designed such that researchers can identify at which amount of immediate 
reward the probability of choosing the immediate or delayed reward becomes 50%, known as 
the indifference point. Based on the hyperbolic function developed by Mazur (1987), the 
indifference point to calculate an empirically derived constant that is proportional to the 
degree of delay discounting for each participant – the k parameter or its log (“Ln(k)”) – one of 
the most commonly interpreted outcomes of DD paradigms. Additionally, is also possible to 
obtain the area under the curve (AUC) as a DD outcome (Yoon et al., 2017), which usually 
shows a parametric distribution of the data and carries no assumptions regarding the 
mathematical form of the temporal discounting function, and is therefore not related to any 
specific economic framework (Myerson et al., 2001).  
DD can be assessed using a variety of techniques, the most commonly implemented 
being the 27-item questionnaire developed by Kirby et al. (1996) (also known as the 
Monetary Choice Questionnaire - MCQ). However, DD can also be assessed via multi-item 
choice tasks (MICT), wherein the amount of immediately available money and delay 
durations are systematically modified (MacKillop et al., 2011). As highlighted by two 
previous meta-analyses (Amlung et al., 2017; MacKillop et al., 2011), several studies have 
shown that substance users differ from non-using controls regarding temporal discounting, 
and that the paradigm can also predict clinically-relevant addictive behaviours such as poor 
treatment response (Washio et al., 2011). In addition, some studies have suggested DD 
behaviour as an addiction endophenotype, due to associations with conduct disorder, attention 
deficit/hyperactivity disorder, high novelty-seeking and poor self-regulation (Anokhin et al., 
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2011; Anokhin et al., 2014). Together, these findings highlight the crucial role of this 
paradigm in tracking individual differences and psychobiological processes that may underlie 
important outcomes across the lifespan (Mischel et al., 2011). 
 
1.2 The Iowa Gambling Task 
The IGT is a computerized behavioural task in which participants are asked to choose 
100 times between four virtual decks (usually labelled A, B, C, and D). After each choice, 
participants can either win, or win and lose money, depending on the ratio of wins and losses 
of each deck. In the beginning of the task participants are informed that some decks are more 
profitable than others. Most often, decks C and D can be categorized as advantageous, 
because they deliver small to moderate rewards with or without small losses, providing a 
positive profit to the participants in the long run. On the other hand, decks A and B are 
disadvantageous, since they deliver moderate to large rewards, but usually large losses as 
well, providing a negative profit to the participants in the long run. The main outcome of the 
IGT is usually the net score, which can be obtained by subtracting the total number of 
selections from disadvantageous decks from the total number of selections from advantageous 
decks.  
The IGT was first introduced to examine the somatic marker hypothesis, which states 
that stronger physiological responses (i.e., somatic markers) occur during anticipation of 
high-risk decisions when compared to low-risk decisions (Bechara et al., 1994). Specifically, 
the authors observed that people with orbitofrontal cortex (OFC) injuries have a decreased 
capacity to produce distinct anticipatory somatic markers, which might explain their worse 
decision-making performance when compared to controls. Intriguingly, similar results have 
also been observed in SUDs samples (Bechara, 2005; Bechara and Damasio, 2002; Bechara et 
al., 2002), contributing to the development of neuroscientific models of addiction that 
emphasise the role of the OFC and the ventromedial prefrontal cortex in the loss of control 
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and compulsive drug use (Verdejo-García and Bechara, 2009). Accordingly, some studies 
have already reported that better IGT net score predicts fewer drinking problems and fewer 
average drinks per year in adolescents, as well as lower relapse rates in polysubstance-
dependent alcohol patients within 3 months after treatment (De Wilde et al., 2013; Xiao et al., 
2009). Likewise, it was shown that subjective weight to gains vs. losses predicted current 
smokers and current smoking levels 1 year later in adolescents (Xiao et al., 2013). In 
conclusion, it has been proposed that SUDs are associated to failures in the induction of 
appropriate somatic markers, contributing to disruptions in self-regulation and the capacity to 
learn from the consequences of actions (Olsen et al., 2015).  
 
1.3 Previous meta-analyses 
Previous meta-analyses have revealed a number of addiction-related effects on 
decision-making processes. MacKillop et al. (2011) meta-analysed data from 46 studies that 
used a DD task comparing a control group with a substance user group (including tobacco, 
alcohol, stimulant, opiate, and polysubstance drug use), as well as samples composed of 
individuals with gambling disorder. Similarly, Amlung et al. (2017) performed a meta-
analysis on 64 studies to investigate the associations between addiction severity and DD 
performance, focusing on SUDs of tobacco, alcohol, cannabis, stimulants, and opiates, and 
gambling disorder. Both meta-analyses indicated that addictive behaviours are indeed 
associated with a reduced capacity to delay gratification, and that this effect was associated 
with continuous measures of addiction severity. 
Regarding the IGT, Kovács et al. (2017) investigated the effects of gambling and 
alcohol use disorders in this task, meta-analysing data from 17 studies. The authors found that 
both alcohol use disorder and gambling disorder impair IGT performance, with higher effects 
for the latter category. Finally, Biernacki et al. (2016) specifically examined the effects of 
current and past opioid use on decision-making, including not only the IGT and the DD, but 
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also the Game of Dice Task, the Balloon Analogue Risk Task, the Cambridge Gambling 
Task, and the Information Sampling Task in one single analysis (see Biernacki et al., 2016, 
for task descriptions). The authors found that opioid users perform worse than controls, with 
evidence suggesting that decision-making deficits may persist at least 1.5 years after cessation 
of use (Biernacki et al., 2016).  
Although these previous meta-analyses all provided important insights into the 
associations of addiction behaviours and decision-making, the evidence gleaned from them is 
limited in three important ways: 
(1) Previous analyses have failed to identify differences concerning the effects of 
specific types of SUDs on DD assessment. Given the high heterogeneity of effect sizes in the 
studies comprised in the meta-analyses of MacKillop et al. (2011) and Amlung et al. (2017) 
meta-analyses, it is possible that the inclusion of samples composed of individuals with 
gambling disorder, nicotine use disorder, and non-clinical samples (e.g., recreational users) 
might have prevented the identification of specific substances associated with a greater impact 
on delayed gratification in relation to other drugs. For instance, larger effects sizes were 
associated with studies performed with clinical rather than nonclinical samples (MacKillop et 
al., 2011). Moreover, nicotine addicts retain autonomous control over their actions, even 
though they lose control over their motivation to smoke (Baumeister, 2017). Therefore, even 
though nicotine addiction leads to clinically significant psychological distress and physical 
long-term consequences, this disorder is unlikely to be associated with problems at work (e.g., 
repeated work absences, poor performance) or incapacity of dealing with family obligations 
(e.g., neglect of children, failure to meet household responsibilities), which are important 
characteristics of alcohol, cocaine, and heroin addiction, among others. This indicates that 
nicotine addiction may have a much slower escalation to such impairments.  
(2) Some meta-analyses included multiple decision-making tasks with different 
conceptual frameworks within the same analysis (Biernacki et al., 2016). While the IGT is 
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clearly a feedback processing decision paradigm where participants should implicitly (re)learn 
by trial and error, the Game of Dice Task can be categorized as decision under risk where the 
risks and the profits are explicit and can be estimated by the agents (Rzezak et al., 2012). On 
the other hand, the DD could be understood as decision under certainty, because the 
probability associated with the profit is always 100% and the task aims to depict choice 
preference as a function of the delayed reward. Although from a psychological perspective all 
tasks investigated by Biernacki et al. (2016) can be categorized as accessing a broad range of 
decision-making, from a neurobiological value-based decision-making framework (Rangel et 
al., 2008; Verdejo-Garcia et al., 2018), each task manipulates information in a different way 
and, therefore, they cannot be assumed to galvanise the same decision processes or to depict 
the same concepts. For instance, the Balloon Analogue Risk Task requires decisions under 
dynamic risk, in which at each single choice – to pump or not to pump a balloon – within a 
trial, participants may consider a trade-off between maximizing their profit in detriment of an 
increasing risk (Lejuez et al., 2002). Moreover, the frequently used Cambridge Gambling 
Task was designed to assess risk-taking behaviour outside a learning context (Rogers et al., 
1999).  
(3) Previous analyses suffer from methodological issues arising from the incorporation 
of multiple effect sizes from a single study. Given that some contributing studies could 
provide more than one clinical sample (e.g., Ahn, WY. 2014; Bickel, WK., 2017; Mejía-Cruz, 
D. 2016), in this case the assumption of independence between outcomes is violated when 
performing a meta-analysis. Kovács et al. (2017) stressed the violation of independency as 
one of their limitations, while MacKillop et al. (2011) included all reported comparisons for 
maximum representativeness and Amlung et al. (2017) opted to repeat the main analysis by 
merging studies with multiple associations into a single effect size. However, ignoring such 
dependencies in the meta-analytical model can lead to biases or lack of efficiency in statistical 
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inference (Gleser and Olkin, 2009). Together, such limitations are crucial when trying to 
clarify specific decision-making behaviours over a general set of disorders, such as addiction. 
 
1.3 Aims of the study 
To overcome the limitations of previous studies, we, therefore, aimed to specifically 
investigate how SUDs affects delayed gratification (DD) and feedback processing (IGT) by 
performing two independent multilevel mixed-effects meta-analyses and univariate and 
multivariate mixed-effects meta-regressions considering demographic and clinical 
moderators. Our main research questions and hypotheses were: 
(1) Is there any difference between the DD and the IGT concerning the magnitude of 
the effect size of SUDs on decision-making behaviour? We therefore performed a meta-
analysis to initially compare both tasks regarding the magnitude of the effect sizes of SUDs in 
comparison to controls. Based on previous meta-analyses, we expect no significant 
differences in the magnitude of the effect sizes of SUDs between both tasks. 
(2) Do specific SUDs differ regarding the magnitude of the effect size on the DD and 
IGT relative to others? Here, we carried out univariate and multivariate meta-regressions, 
separately for each task, to explore both the magnitude of the effect size of different SUDs to 
the controls and the magnitude of the effect size of additional demographic (e.g., years of 
education, percentage of men, age), clinical (e.g., abstinence duration, presence or the absence 
of psychiatric comorbidities), and methodological (e.g., recruitment bias) moderators. We 
expect to find smaller effect sizes for substances with an addictive potential in the lower range 
(Nutt et al., 2007), such as cannabis. By explorative analyses of the other moderators, we 
intend to identify important factors that might attenuate or exacerbate decision-making 




(3) Which demographic, clinical or methodological moderators might have a 
differential effect on the DD relative to the IGT or vice versa? We expect that demographic 
and clinical moderators, such as age and psychopathologies, might have an effect on the DD 
estimates given that the performance in this task has been shown to be influenced by 
individual differences (Steward et al., 2017; Urosevic et al., 2016). Conversely, we expect to 
find an effect for substance use moderators specifically on the IGT, as it was already shown 
that the performance in the IGT can covary with changing cocaine use (Hulka et al., 2015). 
Our findings will provide a basis for a better understanding of how specific SUDs and 
their demographic and clinical contexts relate to decision-making deficits, which have been 







2.1 Literature search and study selection 
The search was performed in MEDLINE Complete, Web of Science Core Collection, 
and EMBASE online databases, from May until October 2018, following the recommendation 
checklist of the Cochrane Guidelines (Higgins and Green, 2011) and the PRISMA guidelines 
for systematic review (McInnes et al., 2018). No restrictions were applied regarding 
publication language or publication date. We searched for studies that specifically reported to 
have measured decision-making using any Delay Discounting task/questionnaire or the Iowa 
Gambling Task and that compared a SUDs group (except for nicotine) to a control group. 
Search terms related to SUDs and the name of the two tasks of interest were used, “(‘Drug 
dependence’) OR (Addiction) OR (‘Substance-related disorders’) AND (‘Iowa Gambling 
Task’) OR (‘Delay Discounting’) OR (‘Intertemporal choice’) OR (‘Delay of gratification’) 
OR (‘Temporal discounting’)”. The search terms were required to be presented in the 
title/abstract or topic and a filter to select only studies with humans was used.  
 
2.2 Inclusion criteria 
A two-step screening of the literature was done. Initially, at the identification phase, 
the results from all databases were merged and the duplicates excluded (based on titles and 
abstracts) using EndNote X7 reference management software (Bramer et al., 2016; Thomson 
Reuters, 2017). Subsequently, references were imported to Rayyan (https://rayyan.qcri.org), a 
free web application for management of systematic reviews. At the second step, full texts 
were screened for inclusion by two authors (BKS and TWV) based on six criteria. (1) Peer-
reviewed published research reporting a comparison between a SUD group and a healthy 
control group. Because we were mainly interested in investigating the effect of SUDs on 
decision-making, articles reporting compulsive disorders, or addictive behavioural disorders 
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not related to substance use (e.g., gambling disorders, binge eating), or studies that did not 
specified any SUD, were not included. (2) Reported on participants aged between 18 and 65 
years. Thus, studies with adolescents and high-risk populations that had not thus far 
developed any SUDs (e.g., history of parental drug abuse or dependency) were not included. 
(3) Studies available in full text format. (4) Provided group means and standard deviations 
from which an effect size could be calculated – if research articles did not provide statistics 
for effect size calculation (i.e., the DD overall estimators or IGT overall net score) the 
corresponding authors were contacted (see also Acknowledgement section). The GetData 
Graph Digitizer (version 2.26.0.20) was used to extract data from figures when corresponding 
authors did not answer.  
Cohen's kappa coefficient (k) was calculated as a measure of interrater reliability 
(IRR), providing a “chance-corrected” percentage of agreement between all the coders. After 
coding, all disagreements concerning the exclusion of a research article were discussed until 
consensus was reached. For more detailed information about the identification, screening, 
reference search, eligibility and inclusion, the flowchart is shown in Figure 1. 
 
2.3 Decision-making measures 
This review included studies that reported DD or IGT measures only, performing 
independent analyses for each task (please, see section 2.5 Meta-analytic and meta-regression 
approach). This is an important distinction because our rationale was based on a 
neurobiological value-based framework (Rangel et al., 2008; Verdejo-Garcia et al., 2018) that 
distinguish valuation and choice implementation (DD) from feedback processing (IGT).  
 
2.4 Data extraction 
The following data were extracted for each study: (a) number of participants in each 
group and (b) group means and standard deviations of the DD and/or IGT. Additionally, for 
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each study, we extracted the averaged demographic, clinical/methodological moderators (i.e., 
years of education, percentage of men, age, abstinence duration before the testing session in 
weeks and recruitment bias) for the SUD samples. As some studies reported more than one 
clinical group, one with people with SUDs and the other one composed with people with 
SUDs plus an additional psychiatric disorder, a dichotomous predictor was included to 
identify the presence or the absence of psychiatric comorbidities. Based on the mean 
abstinence duration before the testing session a dichotomous predictor was build: SUD in 
early remission according to DSM 5 (>12 weeks of abstinence) or not (<12 weeks of 
abstinence) (APA, 2013). SUDs were coded as alcohol, cannabis, stimulants (cocaine, 
amphetamine and its derivatives, respectively), opioids (heroin and opiate substitutes such as 
methadone or buprenorphine, respectively), and polysubstance SUD. Polysubstance SUD was 
coded if this diagnosis was directly reported but also when participants with more than one 
diagnosed SUD were included in the same sample in a study. The data were independently 
extracted by three authors (BKS, BSV, and TWV). During this process, any doubt was 
immediately discussed between the three authors. Finally, the methodological quality of each 
included study was rated independently by two reviewers (BKS and BSV) using the 
Newcastle-Ottawa scale (Stang, 2010). A Cohen's kappa coefficient (k) was calculated 
between the two authors. 
 
2.5 Meta-analytic and meta-regression approach 
The statistical analyses were performed in three main steps. First, we performed a 
meta-analysis to investigate whether the magnitude of effect of SUDs differed regarding DD 
and IGT. This step was taken even though we clearly distinguished delayed gratification 
processes from feedback processing at a theoretical level. In a second step, two independent 
meta-analyses were performed to investigate the magnitude of effect of SUDs for each task 
(DD and IGT).  
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In a third step, univariate meta-regression models were used to explore the moderating 
effects of each demographic and clinical/methodological variables on both the DD and the 
IGT standardized mean differences, separately, using Q-statistics. Subsequently, as a 
complementary meta-regression procedure, multivariate meta-regression models including the 
most influential demographic and clinical/methodological variables were performed for both 
the DD and the IGT standardized mean differences, separately. All the moderators that 
contributed to heterogeneity in mean estimates at p<0.2 in the univariate meta-regression 
models were included in the multivariate meta-regression models (Polanczyk et al., 2015; 
Viola et al., 2016). The estimated proportional reduction in the total variance for both the 
univariate and multivariate meta-regression models were computed using the variance 
accounted for (VAF), a pseudo R-squared value.  
In order to overcome previous methodological constraints regarding the heterogeneity 
of the studies, the violation of the independency assumption within studies, the overweighting 
of the effect sizes, and the correction for multiple comparisons, appropriate analytical 
strategies were adopted in all data analyses. Initially, concerning the effect size heterogeneity, 
both Cochran’s Q (sum of squared differences between individual weighted study effects and 
the overall mean) and I-squared
 
(percentage of variation within study effect sizes that can be 
explained by heterogeneity) indices were calculated.  
Because significant results for the Q tests and moderate I-squared values were 
considered as indicators of heterogeneity, we performed multilevel linear mixed-effects meta-
analytical models based on the standardized mean differences with the maximum likelihood 
estimator (Huedo-Medina et al., 2006; Kelley and Kelley, 2012) in all steps described above. 
This strategy allowed us to account for the heterogeneity of the studies and the fact that some 
studies brought data from independent SUDs subgroups contributing with multiple different 
effect sizes – given that some studies with more than one independent SUDs subgroups 
compared these groups with the same control group. In this regard, in our models the 
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subsamples of a given study received the same identification and thus, the same random 
effects, while effects from different studies were assumed to be independent. Additionally, we 
also included the methodological quality as random effects in both main meta-analyses (DD 
and IGT) and all disagreements concerning the exclusion of a research article were discussed 
until consensus was reached. 
Furthermore, because DD studies used either the MICT or the MCQ and reported 
either the k, Ln(k), or AUC index, we therefore included these variables in our main DD 
meta-analytical model. The type of the index variable was included as a fixed effect, given 
that we were interested in investigating whether the indices (k, Ln(k), AUC) differ from each 
other regarding the magnitude of their effect size. In contrast, the DD task type (i.e., MCQ or 
MICT) was included as a random effect, as it was already shown that the different task types 
revealed comparable effect sizes in SUD (Amlung et al., 2017; Addiction), and we therefore 
were interested in the variation reflected by the different levels of task type in the overall 
magnitude of the effect size, but not in the effect of each different level of the variable. Using 
the same strategy as Amlung et al. (2017), the signs for associations using k and Ln(k) were 
reversed prior to inclusion in the analysis, since they are inversely related to AUC and IGT 
score.  
However, because performing multilevel linear mixed-effects meta-analytical models 
are not sufficient to completely deal with the violation of the independency assumption within 
studies, a variance-covariance matrix of the effect size estimates was calculated based on 
Gleser & Olkin (2009) and then incorporated into the models. Additionally, following the 
Cochrane guidelines, an overweighting of the effect sizes was counteracted by dividing the 
sample size of the shared control group by the number of comparisons with independent 
clinical groups from the same study.  
Finally, although few outliers were expected due to the large number of studies and 
samples retrieved (Voyer and Voyer, 2014), small study bias and influential cases were 
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investigated by examining the standardized residual for each study and checking for outliers 
(Biernacki et al., 2016; Viechtbauer and Cheung, 2010). The influence of studies that had a z-
scores of greater than ±1.96 was examined using the “leave one out” method. Hence, the 
results of our meta-analysis were recalculated n-1 times, each time leaving out one possible 
influential study (Viechtbauer, 2010). If the studies did not substantially change the overall 
effect size, we opted to retain them in the overall analyses. Publication bias was assessed by 
visually inspecting funnel plots and by calculating Rosenthal’s fail-safe N, which calculates 
the number of studies averaging null results that would have to be added to the given set of 
observed outcomes in order to reduce the combined significance level (p-value) to a target 
alpha level (e.g., .05) (Rosenberg, 2005; Rosenthal, 1979), wherein a larger N indicates more 
confidence in the findings.  
Estimate effect sizes of each individual study are shown in forest plots, in which 
negative estimated effect sizes represents the deleterious effect of the SUD on the DD or IGT. 
All analyses were performed using the package “metafor” (version 2.0-0) (Viechtbauer, 2010) 







3.1 Included articles 
As shown in Figure 1, 1662 articles were initially found. After excluding duplicated 
entries 962 articles were screened to check against the exclusion criteria, resulting in 97 
articles being retained (IRR, k=.848). In addition to the main literature search, references of 
four previous meta-analysis were screened and 15 new studies were found. From a total of 
112 research articles we identified that 6 of them had republished data or a significant overlap 
between reported samples and, therefore, they were excluded, resulting in 106 research 
articles that were elected to be individually fully reviewed. The means and standard 
deviations from 5 of the articles, for which we received no answer from the authors, were 
estimated by using the open source software for data extraction GetData Graph Digitizer 
(version 2.26.0.20). We were not able to include data from 19 studies, because for 6 of these 
studies the authors stated that they had no longer access to the data and regarding 13 further 
studies the authors did not respond to our requests. As these 19 studies did not include figures 
representing the main DD and IGT variables, the GetData Graph Digitizer could not be used. 
Additionally, 4 studies were excluded because SUDs were not specified. In the end, 83 
research articles (31 using DD, 44 using IGT, and 8 using both the DD and the IGT) and 115 
comparisons (49 for the DD and 66 for the IGT) were considered viable for data analysis. For 
clinical trials and longitudinal study designs, only one sample was included; either the 
condition without treatment or the baseline measurement, respectively. The IRR of the 
methodological quality total score was .720, for detailed information, please see Table S1. 
The reference list of all included studies can be found in the supplementary material.  
 




3.2 Sample characteristics 
Table 1 displays the mean and SD for the chosen moderators per substance and for 
each task. Studies investigating alcohol-related disorders provided the highest number of 
participants in both tasks, while studies investigating cannabis-related disorders generated the 
lowest number of participants. As expected, the percentage of men among all studies was, on 
average, two-thirds of the total sample. Cannabis also showed the shortest abstinence period 
when compared to the other substances.  
 
---------- TABLE 1 ---------- 
 
3.3 Meta-analyses and meta-regressions 
Initially, when investigating whether SUDs might have a different impact on DD and IGT, 
we found a significant effect on the standardized mean differences of DD when compared to 
IGT (β=-.30, CI 95% [-.41, -.19], Q[1]=30.06, p<.001). This result was sustained even when 
removing outliers (β=-.27, CI 95% [-.38, -.17], Q[1]=27.43, p<.001). Based on our theoretical 
background – that IGT and DD probe different decision-making processes – and supported by 
our finding that a significant smaller effect with a larger dispersion was found for DD when 
compared to IGT, our next analytical steps were independently performed for each task 
(Figure 2 and Figure 3). 
At the second step and concerning the DD, our results revealed a significant effect of 
SUDs (β=-.70, CI 95% [-1.22, -.19], Q[46]=189.11, p<.001), even when removing outliers 
(β=-.68, CI 95% [-1.15, -.21], Q[43]=147.40, p<.001). No significant differences were found 
concerning the DD indices (i.e., AUC, k or Ln(k); Q[2]=.95, p=.621). Similarly, regarding 
IGT an effect for SUDs was also found (β=-.55, CI 95% [-.66, -.43], Q[66]=327.34, p<.001), 
remaining significant after removing outliers (5% of the included sample of studies) (β=-.47, 
CI 95% [-.56, -.38], Q[60]=109.28, p<.001). Rosenthal’s classic fail-safe N indicated that 
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there would need to be 3969 unpublished studies to raise the p-value to above the threshold 
for statistical significance for the DD primary analysis and 7167 to raise the p-value to above 
the threshold for statistical significance for the IGT primary analysis (funnel plots can be 
found in the supplementary material; S1, S2 and S3). As depicted in Figure 2 and Figure 3, 
independent meta-analyses for each substance revealed no significant effect for cannabis use 
disorders on the IGT and DD. 
As a third step, we performed multilevel univariate meta-regressions for each task 
independently. With regards to the DD, multilevel univariate meta-regression models revealed 
a positive effect for years of substance consumption, a negative effect for early onset of 
substance consumption (i.e., the ratio between years of substance consumption and age), and 
a negative effect for psychiatric comorbidities (Table 2). Additional pairwise comparisons 
showed a significant positive effect for stimulants when compared to polysubstance 
dependence, only (Table 3), suggesting that the effect of polysubstance related disorder is not 
as deleterious as the effect of stimulant related disorders. In contrast, concerning the IGT, the 
models showed a significant positive effect for cannabis related disorders when compared to 
alcohol (Table 2), and additional pairwise comparisons also suggested a similar significant 
positive effect for cannabis when compared to stimulants, opioids, and polysubstance 
dependence (Table 3). These findings suggest the effect of cannabis related disorders are not 
as deleterious as the effect found for other SUDs.  
 
---------- FIGURE 2 ---------- 
 
---------- FIGURE 3 ---------- 
 
As a complementary meta-regression procedure, we performed two multilevel 
multivariate meta-regression models, one for each task. Although the effect of cannabis over 
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alcohol was not observed anymore for the IGT, the effect of remission remained as a trend 
(p=.053) (Table 2). Similarly, additional pairwise comparisons showed an effect of cannabis 
when compared with stimulants, opioids, and polysubstance SUDs (Table 3). For the DD, the 
multilevel multivariate meta-regression model revealed an effect for early onset of substance 
consumption and for psychiatric comorbidities (Table 2). Because no robust effect was found 
for any substance in the DD, no additional pairwise comparisons were performed for this task. 
Finally, because our stimulant group included cocaine and amphetamine type users as well, 
we explored whether the later (i.e. amphetamines derivate) have differential effects on IGT 
and DD. No effect was found for the IGT (β=.09, CI 95% [-.23, .42], p=.570), but a 
significant effect was observed for the DD (β=-.36, CI 95% [-.70, -.02], p=.038), suggesting 
that other stimulants have a smaller effect when compared to cocaine. However, it must be 
highlighted that this effect is driven by only 4 studies on stimulants other than cocaine, in 
comparison with 11 studies on cocaine use.  
 
---------- TABLE 2 ---------- 
 







The primary aim of this study was to explore the influence of SUDs and demographic, 
clinical features, and methodological moderators on two main facets of decision-making: 
valuation processing (assessed through the DD) and feedback processing (assessed through 
the IGT). In total, 88 studies were taken into account and different subsets were generated 
depending on the respective research questions. Our main results suggest that: (1) the 
magnitude of the difference between the effect sizes among samples with and without SUDs 
is moderate, and SUDs are generally associated with impaired valuation of delayed 
gratification (b=-.305) and impaired feedback processing (b=-.423); (2) the effect of cannabis 
use disorder on feedback processing is not as deleterious as the effect of other SUDs; (3) there 
are no robust differences between the effect of diverse SUDs on valuation of delayed 
gratification; and (4) early onset of substance consumption and presence of psychiatric 
comorbidities is associated with stronger effect of SUDs specifically on valuation of delayed 
gratification. 
With regards to the main effect of SUDs on decision-making processes, our results are 
in accordance with previous meta-analyses. With respect specifically to valuation processing, 
some studies already showed that people with SUDs and gambling disorders performed worse 
than non-user controls on the DD, while no differences were found between the MICT and the 
MCQ (Amlung et al., 2017; MacKillop et al., 2011). Regarding feedback processing, our 
results support the finding that the observed impairments on the IGT seem to vary according 
the addictive disorder (Kovacs et al., 2017), with no significant difference in the magnitude of 
the effect on those people with and without psychiatric and neurological co-morbidities 
(Biernacki et al., 2016). However, our empirical results contrast with a recent systematic 
review that proposed that there is no current evidence supporting the view that chronic 
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cocaine use is associated with broader decision-making impairments (Frazer et al., 2018). By 
performing meta-analyses and multilevel meta-regressions on feedback processing, our results 
reveal a robust effect of stimulants, opioids and polysubstance SUDs over cannabis, even 
when using a multivariate model. 
The idea that stimulant users might perform worse on cognitive tasks compared with 
cannabis users was recently shown by Kaag et al. (2018). Neuroimaging data support these 
findings, given that a negative correlation between lifetime cocaine use and grey matter 
volume of the prefrontal cortex has been observed, while there were no positive or negative 
associations between grey matter volume and lifetime cannabis use (Kaag et al., 2018). 
Likewise, we here did not observe that cannabis abusers presented decision-making deficits 
when compared to non-substance abusers. However, this finding must be interpreted with 
caution considering the small number of included studies, pinpointing the necessity for more 
research into the adverse effects of cannabinoid use and decision-making processes (Curran et 
al., 2016).  
Moreover, and together with our previous findings (Kluwe-Schiavon et al., 2016), the 
effect of SUDs on learning from feedback proffers some important hypotheses on how these 
processes interact. We have shown in this prior study that women with crack-cocaine use 
disorder were able to adjust their risk-taking behaviour when facing immediate feedback on a 
decision-making task. It must be noted that, however, that we used the Columbia Card Task, a 
decision-making task under explicit risk where the feedback occurs immediately after the 
participant’s choice, while the IGT is a decision-making task under uncertainty and implicit 
learning where participants must ‘relearn’ that what they initially thought was a good deck to 
choose from was, indeed, a bad deck in the long term. With this difference in mind, future 
studies could specifically investigate how SUDs may affect learning from feedback in both 
explicit risk and uncertainty-dependent decision-making scenarios. 
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Furthermore, our moderators’ analyses also seem to be in accordance with earlier 
findings. Concerning valuation of delayed gratification processing, Amlung et al. (2017) 
found an association between continuous measures of addiction severity and worse 
performance on the DD, while MacKillop et al. (2011) found larger effect sizes for studies 
using clinical samples when compared with studies using nonclinical samples. Of note, both 
Amlung et al. (2017) and MacKillop et al. (2011) included also non-SUDs samples, while we 
included SUDs samples only. Such a difference might explain the stronger association 
between the variability on DD performance and substance use severity that previous studies 
found. Despite this, in our study we observed a significant effect on DD concerning the ratio 
between years of substance consumption and age – which one could infer to be an index of 
the years of consumption adjusted to individual age at the time of the measurement – in which 
small ratios represent a shorter period of consumption in relation to the individual age. This 
finding also suggests that alterations in valuation of delayed gratification are associated with 
earlier onset of substance consumption, which corroborates the literature regarding substance 
consumption and decision-making and impulsive behaviour during adolescence (Audrain-
McGovern et al., 2009). 
Remarkably, our results may suggest that remission can have an effect on feedback 
processing, by suggesting that people that were not using substances over 12 weeks prior to 
the measurement performed better than those that were not remitted. Although this result is 
not significant, this trend is in line with previous studies from our lab that revealed that 
cocaine users who substantially decreased the amount of cocaine consumption over one year 
showed improved performance regarding attention, working memory, declarative memory, 
and executive functions (Vonmoos et al., 2014), key cognitive functions involved in learning 
and decision-making. In the present analysis, the average of weeks in remission over all 
SUDs samples that performed the IGT was 23, suggesting that after this period it is possible 
to nevertheless observe some improvement trends on IGT performance. This does not mean 
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that people with SUDs will perform as well as people without SUDs, or that this improvement 
might be directly observed in daily life situations. However, this was a trend only, and it may 
be interpreted as a potential marker of interest for future studies.  
Taken together, our findings suggest that valuation processing is not specially affected 
by different substances of abuse and other SUDs related moderators, while feedback 
processing might be more vulnerable for SUDs specific effects. Therefore, it is reasonable to 
hypothesize that individual differences in valuation processing of delayed gratification, such 
as psychiatric disorders (e.g. ADHD) and developmental stages, can trigger risk-taking 
behaviours and might lead to the beginning of substance use. Once a recurrent substance use 
pattern is established, it can lead to alterations in feedback processing, resulting in the 
maintenance of the consumption despite the negative consequences of it (Bolla and Cadet, 
2007). In accordance with this, opponent process theories of addiction have postulated that 
SUDs are triggered by a dysregulated brain reward function and the recruitment of antireward 
systems that drive the compulsive substance-related behavior by diminishing the aversive 
states in spite of the associated risks (Bickel et al., 2018). Moreover, the idea that delay 
discounting may reflect a temporally stable individual trait is not new (Odum, 2011), and it 
was already shown that delay discounting might have predictive effects on regular smoking 
during adolescence (Audrain-McGovern et al., 2009) and treatment response for heavy 
drinkers (MacKillop and Kahler, 2009). Longitudinal future studies may focus on this issue 
by, for instance, investigating whether delay discounting performance can predict the onset 
of, or changes in, substance consumption patterns of people with SUDs. Meanwhile, our 
results can be interpreted in line with the idea that DD could be deeper investigated as an 
addiction endophenotype, as it is less specifically associated with SUDs moderators, but 






Although we overcame several methodological constraints of previous meta-analyses 
(e.g., violation of the independency assumption within studies, the overweighting of effect 
sizes, and the correction for multiple comparisons), our results might be interpreted in light of 
some limitations. First, we only included peer-reviewed articles listed in established research 
databases, neglecting other materials or/and researches produced by organizations outside of 
the academic publishing channels, which may have influenced effect sizes and publication 
biases of our analyses. However, the benefits and challenges of including so called “grey” 
literature are still a matter of debate (Paez, 2017). Second, case groups were considered as 
“polysubstance SUD” if they were directly reported as polysubstance SUD but also when 
participants with more than one SUD were included in a study. Therefore, the surprising 
finding that the effect on DD was smaller in polysubstance than in the stimulants class might 
reflect poorly defined consumption patterns of the polysubstance category. Accordingly, it 
should be noted that we did not specifically account for severity of substance use given that 
there was not a standard measure of severity across the included studies. However, we 
included clinical moderators such as years of consumption, remission, recruitment bias that 
could be understood as indirect indicators of substance-related disorders severity. 
Third, here we investigated DD and IGT as key tasks used to access temporal discounting 
and feedback processing, respectively. However, the outcomes measured in both tasks also 
engage other decision-making stages and, therefore, impairments on both DD and IGT cannot 
be understood, exclusively, as deficits in choice implementation and feedback processing. For 
example, choice implementation comprises different processes such as response initiation, 
self-regulation, cognitive inhibition; while it is known that the IGT requires the valuation of 
decision options with ambiguous outcomes, a component of preference formation 
representing an earlier decision-making stage (Verdejo-Garcia et al., 2018). Moreover, it is 
also possible that several other cognitive functions involved in both choice implementation 
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and feedback processing, that have been reported to be susceptible to SUD, such as working 
memory and executive functioning (Vonmoos et al., 2018; Vonmoos. et al., 2014), played an 
important role in the decision-making outcomes that we showed. Finally, we could not assess 
and, therefore, include in our analysis the co-use of other substances (even of tobacco and 
alcohol) beyond the main SUD, as this information was not systematically assessed in most of 
the included studies. The lack of this information should be acknowledged as a potential 
limitation of the present analysis and argues for a standardized assessment and reporting of 
co-used substances in our field in the future. Nevertheless, our meta-analysis considered the 
two most established tasks that access decision-making in SUDs and intended to investigate 
these two key processes involved in decision-making. 
 
4.2 Conclusion 
Our results extend the current literature in three main ways. Firstly, we showed that SUDs 
are associated with impairments in the implicit learning from feedback processing and 
valuation of delayed gratification. Secondly, we replicated previous findings showing no 
differences between distinct SUDs on the valuation of delayed gratification impairments. 
However, our data indicates that cannabis related disorders have a smaller negative effect on 
implicit learning from feedback processing when compared to other substances, suggesting 
that either cannabis related disorders are not as deleterious as other SUDs or that cannabis 
dependent users do not have stronger decision-making impairments as other SUDs. Thirdly, 
we demonstrated that remission might have a positive effect on IGT performance, and that 
early onset of substance consumption and psychiatric comorbidities are associated with worse 
DD performance, advocating for the hypothesis that deficits in valuation of delayed 
gratification can precede deficits in feedback processing in SUDs. Lastly, in this study 
multilevel linear mixed-effects meta-analytic and meta-regression models were used, for the 
first time, to investigate the effect of SUDs on two different decision-making processes, 
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Table 1. Sample characteristics and descriptive data from moderators per substances (sample size numbers and means and standard deviations 
in parenthesis are shown).  
 Alcohol Cannabis Stimulants Opioids Polysubstance SUD 
Delay Discounting Task      
     Number of participants SUD 867 135 508 329 671 
     Number of participants HC 627 143 547 318 507 
     SUD characteristics      
          Age 35.2 (11.3) 30.0 (3.3) 35.1 (6) 37.1 (6.6) 40.7 (5.8) 
          % of men in the SUD sample 73.6 (15.6) 64.2 (31) 76.4 (17.1) 68.2 (19.7) 79.0 (11.5) 
          Abstinence duration (weeks) 10.0 (22.8) 0.79 (-) 12.9 (26.3) 57.9 (42.7) 21.0 (27.6) 
          SUD recruitment      
               Flyers/newspapers/internet 7 1 6 4 9 
               Prevention/treatment centres 2 1 9 2 1 
               Inpatient care facility 2 0 2 1 0 
Iowa Gambling Task      
     Number of participants SUD N=654 N=213 N=421 N=683 N=573 
     Number of participants HC N=752 N=194 N=443 N=630 N=483 
     SUD characteristics      
          Age 42.1 (8.7) 23.0 (2.4) 34.6 (10.1) 34.4 (4.6) 34.6 (7.6)  
          % of men in the SUD sample 76.6 (20.5) 80.3 (18) 80.0 (13.4) 86.9 (16.7) 62.8 (27.3) 
          Abstinence duration (weeks) 19.8 (32.5) 0.42 (.35) 20.3 (38.6) 44.7 (48.6) 31.3 (18.2) 
          SUD recruitment      
               Flyers/newspapers/internet 4 5 7 3 6 
               Prevention/treatment centres 6 0 4 9 6 
               Inpatient care facility 10 0 3 1 1 
 
Note: HC, healthy controls; SUD, substance use disorder. 
 
   
Table 2 Multilevel univariate and multivariate meta-regression models for the Iowa Gambling Task and Delay Discounting. 
  Univariate models   Multivariate models 
 n (k) Coefficient SE 95% CI p-value VAF (%)  n (k) Coefficient SE 95% CI p-value VAF (%) 
Delay Discounting              
    DD Index              
        AUC  5 (6) Reference    .02        
        k 10 (11) .27 .28 [-.28, .83] .332         
        Ln(k) 22 (32) .17 .25 [-.33, .67] .503         
    Substance Use Disorder              
        Alcohol 12 (12) Reference    .08        
        Cannabis 3 (3) .12 .19 [-.25, .51] .515         
        Stimulants 15 (17) -.20 .11 [-.42, .02] .086         
        Opioids 6 (7) -.05 .13 [-.32, .20] .672         
        Polysubstance 8 (10) .06 .10 [-.13, .26] .522         
    Demographics              
        Age 37 (49) -.01 .00 [-.03, .00] .143 .08        
        Years of education 23 (33) .12 .06 [-.00, .26] .058 .03  10 (13) -.05 .10 -.26 to .15 .596 .16 
        % of men in the SUD sample 34 (42) -.00 .00 [-.01, .00] .704 .03        
    Clinical / Methodological              
        Years of consumption 19 (22) .03 .01 [.00, .06] .013 .33        
        Years of consumption/Age 19 (22) -.08 .03 [-.14, -.02] .009 .37   -.08 .03 -.15 to -.00 .027  
        Remission (< 12 weeks) 23 (30) -.12 .18 [-.48, .22] .481 .04        
        Psychiatric Comorbidities 24 (31) -.24 .08 [-.40, -.07] .005 .29   -.48 .22 -.91 to .04 .030  
        Recruitment              
             Flyers/newspapers/internet 18 (27) Reference    .13        
             Prevention/treatment centres 13 (15) .02 .17 [-.31, .37] .877         
             Inpatient care facility 4 (5) -.22 .26 [-.74, .29]  .395         
Iowa Gambling Task              
    Substance Use Disorder        22 (32)     .29 
        Alcohol 17 (21) Reference    .05  8 (12) Reference     
        Cannabis 5 (5) .45 .19 [.07, .83] .018   3 (3) .30 .37 -.43 to 1.04 .417  
        Stimulants 13 (14) -.06 .12 [-.30, .18] .622   11 (12) -.36 .24 -.84 to .11 .147  
        Opioids 12 (13) -.06 .12 [-.31, .18] .613   6 (6) -.42 .27 -.96 to .11 .122  
        Polysubstance 11 (13) -.05 .10 [-.26, .15] .625   4 (4) -.42 .27 -.95 to .11 .124  
    Demographics              
        Age 51 (66) -.00 .00 [-.02, .00] .196 .08   -.00 .01 -.03 to .02 .594  
        Years of education 36 (50) .06 .04 [-.02, .15] .130 .79   .15 .08 -.01 to .32 .069  
        % of men in the SUD sample 49 (52) .00 .00 [-.00, .00] .981 .04        
    Clinical / Methodological              
        Years of consumption 34 (45) -.01 .01 [-.03, -.00] .218 .46        
        Years of consumption/Age 34 (45) .03 .03 [-.03, .10] .373 .42        
        Remission (< 12 weeks) 37 (48) .19 .14 [-.08, .47] .170 .41   .42 .21 -.00 to .85 .053  
        Psychiatric Comorbidities 38 (52) -.05 .08 [-.22, .10] .497 .71        
        Recruitment              
             Flyers/newspapers/internet 17 (25) Reference    .03  8 (11) Reference     
             Prevention/treatment centres 21 (25) -.24 .16 [-.56, .06] .126   9 (15) -.18 .42 -1.01 to .64 .660  
             Inpatient care facility 12 (15) -.09 .13 [-.36, .17] .478   9 (11) .68 .42 -.14 to 1.52 .107  
 
Note: CI, confidence interval; k, number of comparisons; n, number of studies; SE, standard error; SUD, substance use disorder; VAF, variance accounted for. Significant p-values are shown in bold. 
The results are shown in line with their respective moderator. 
   
 
Table 3 Pairwise comparisons of substance classes using univariate and multivariate multilevel meta-regressions. 
  Univariate models  Multivariate model 
Reference category Comparative category Coefficient SE 95% CI p-value  Coefficient SE 95% CI p-value 
Delay-Discounting            
     Cannabis Stimulants -.32 .16 -.65 to .00 .052      
     Cannabis Opioids -.18 .21 -.59 to .23 .383      
     Cannabis Polysubstance  -.06 .20 -.45 to .33 .759      
     Stimulants Opioids .14 .14 -.13 to .41 .308      
     Stimulants Polysubstance  .26 .12 .02 to .51 .034      
     Opioids Polysubstance .12 .13 -.15 to .39 .377      
Iowa Gambling Task           
     Cannabis Stimulants -.51 .18 -.88 to -.14 .005  -.66 .29 -1.25 to -.08 .024 
     Cannabis Opioids -.52 .19 -.90 to -.13 .007  -.73 .34 -1.39 to -.06 .031 
     Cannabis Polysubstance  -.50 .19 -.89 to -.12 .008  -.72 .32 -1.37 to -.08 .027 
     Stimulants Opioids -.00 .11 -.23 to .22 .973  -.06 .15 -.37 to .25 .702 
     Stimulants Polysubstance  .00 .11 -.21 to .23 .937  -.05 .14 -.34 to .23 .703 




Figure 1. Flowchart.  
Note: 
a
 Studies investigating any other than targeted SUD (e.g., nicotine use disorder), 
behavioural addictions (e.g., gambling disorder, eating disorder, sex addiction disorder), or 
that did not include adults. 
b 
Conference abstracts, book chapters. 
c
 No empirical studies, such 





 Studies that have used a modified version of the tasks or any other 
decision-making task than the Iowa Gambling Task and Delay Discounting. 
e 
Studies that did 
not include a control group sample. 
 


















Figure S1.  


















Newcastle-Ottawa Quality Assessment Scale ratings.  
  Selection Comparability Exposure  
  Q1 Q2 Q3 Q4 Q1 Q1 Q2 Q3 Total 
sum 
(0-9) 
Ahn, WY. et al. (2016a) 
IGT+D
D 
1 1 1 1 0 
0 1 0 
5 
Ahn, WY. et al. (2016b) 
IGT+D
D 
1 1 1 1 0 
0 1 0 
5 
Ahn, WY. et al. (2014) IGT 1 1 1 1 2 0 1 0 7 
Albein-Urios, N. et al. (2012) DD 1 0 1 1 1 0 1 0 5 
Balconi, M. et al. (2014) IGT 1 0 0 0 0 0 1 0 2 
Ballard, ME. et al. (2015) DD 1 1 1 1 2 0 1 0 7 
Banca, P. et al. (2016) DD 1 1 0 1 0 0 1 0 4 
Barry, D. et al. (2008) IGT 1 1 1 0 2 0 1 0 6 
Bernhardt, N. et al. (2017) DD 0 1 1 1 2 0 1 0 6 
Bickel, WK. et al. (2017) 
IGT+D
D 
1 1 1 1 2 
0 1 0 
7 
Biernacki, K. et al. (2018) IGT 0 1 1 1 0 0 1 0 4 
Bjork, JM. et al. (2004) DD 1 1 1 1 1 0 1 0 6 
Bobova, L. et al. (2009) DD 0 0 1 1 2 0 1 0 5 
Bolla, KI. et al. (2003) IGT 1 1 1 1 0 0 1 0 5 
Bolla, KI. et al. (2005) IGT 1 1 1 1 0 0 1 0 5 
Bottesi, G. et al. (2015) IGT 1 1 1 1 0 0 1 0 5 
Brevers, D. et al. (2014) IGT 1 1 1 1 0 0 1 0 5 
Businelle, MS. et al. (2010) DD 1 1 1 0 2 0 1 1 7 
Contreras-Rodríguez, O. et al. (2015) DD 1 0 1 1 2 0 1 0 6 
Cordovil, M. et al. (2010) IGT 1 1 1 0 0 0 1 0 4 
Cousijn, J. et al. (2013) IGT 1 1 1 1 2 0 1 0 7 
Crunelle, CL. et al. (2013) DD 1 1 1 1 0 0 1 0 5 
Cunha, PJ. et al. (2011) IGT 1 1 1 1 0 0 1 0 5 
Dolan, SL. et al. (2008) IGT 1 1 1 0 0 0 1 0 4 
Dom, G. et al. (2006) IGT 1 1 1 1 2 0 1 0 7 
Duarte, NA. et al. (2012) IGT 1 0 0 1 0 0 1 0 3 
Gonzalez, R. et al. (2012) IGT 1 1 1 1 2 0 1 0 7 
Gonzalez, R. et al. (2007) IGT 1 1 1 1 2 0 1 0 7 
Goudriaan, A. et al. (2005) IGT 1 1 1 1 0 0 1 0 5 
Gullo, MJ. et al. (2011) IGT 0 1 1 1 2 0 1 0 6 
Hanson, KL. et al. (2008) IGT 1 1 1 1 0 0 1 0 5 
Heil, SH. et al. (2006) DD 0 1 1 0 0 0 1 0 3 
Hoffman, WF. et al. (2008) DD 1 1 0 1 0 0 1 0 4 
Hoffman, WF. et al. (2006) DD 1 1 1 1 1 0 1 0 6 
Hulka, LM. et al. (2014) 
IGT+D
D 
1 1 1 1 2 
0 1 0 
7 
Johnson, MW. et al. (2012) DD 0 1 1 1 0 0 1 0 4 
Kim, YT. et al. (2011) IGT 1 1 1 1 1 0 1 0 6 
Kirby, KN. et a. (1999) DD 0 1 0 0 2 0 1 0 4 
Kirby, KN. et al. (2004) DD 0 0 1 0 2 0 1 0 4 
Kjome, KL. et al. (2010) IGT 1 1 1 1 2 0 1 0 7 
Kräplin, A. et al. (2014) IGT 1 1 1 1 2 0 1 0 7 
Le Berre, AP. et al. (2014) IGT 1 1 1 1 2 0 1 0 7 
Ledgerwood, DM. et al. (2009) DD 1 1 1 1 0 0 1 0 5 
Lemenager, T. et al. (2011) IGT 0 1 1 0 2 0 1 0 5 
Li, X. et al. (2013) 
IGT+D
D 
1 1 1 1 2 
0 1 0 
7 
Loeber, S. et al. (2009) IGT 1 1 1 1 2 0 1 0 7 
Ma, X. et al. (2015) IGT 1 1 1 1 0 0 1 0 5 
MacKillop, J. et al. (2007) DD 1 1 1 1 2 0 1 0 7 
Madden, GJ. et al. (1997) DD 1 0 0 0 0 0 1 0 2 
McHugh, M. et al. (2014) IGT 1 1 0 0 0 0 1 0 3 
Meade, CS. et al. (2017) DD 1 1 1 1 1 0 1 0 6 
Mejía-Cruz, D. et al. (2016) DD 1 1 1 1 0 0 1 0 5 
Mellentin, AI. et al. (2013) IGT 1 1 1 0 0 0 1 0 4 
Miranda, R. et al. (2009) IGT 1 1 1 1 1 0 1 0 6 
Monterosso, JR. et al. (2007) DD 1 1 1 1 0 0 1 0 5 
Moody, L. et al. (2016) DD 1 1 1 1 2 0 1 0 7 
Murray, DE. et al. (2015) IGT 1 1 1 1 2 0 1 0 7 
Peisker, CB. et al. (2018) DD 1 1 1 1 0 0 1 0 5 
Petry, N. et al. (1999) DD 1 1 1 0 0 0 1 0 4 
Pirastu, R. et al. (2006) IGT 0 0 0 1 2 0 1 0 4 
Quednow, BB. et al. (2007) 
IGT+D
D 
1 1 1 1 0 
0 1 0 
5 
Robles, E. et al. (2011) DD 0 1 1 1 0 0 1 0 4 
37 
 
Rotheram-Fuller, E. et al. (2004) IGT 1 1 0 1 2 0 1 0 6 
Schmaal, L. et al. (2014) DD 1 1 0 1 2 0 1 0 6 
Sommer, C. et al. (2017) DD 1 1 1 1 0 0 1 0 5 
Stevens, L. et al. (2015) DD 1 1 1 1 2 0 1 0 7 
Strickland, JC. et al. (2017) DD 1 1 1 1 2 0 1 0 7 
Sun, Y. et al. (2016) IGT 1 1 1 1 2 0 1 0 7 
Taylor, EM. et al. (2016) DD 1 1 1 1 1 0 1 0 6 
Tomassini, A. et al. (2012) IGT 1 1 0 0 0 0 1 0 3 
Valladares, AI. et al. (2011) IGT 0 1 1 1 1 0 1 0 5 
van Toor, D. et al. (2011) IGT 0 1 0 0 2 0 1 0 4 
Vassileva, J. et al. (2013) IGT 1 1 1 1 0 0 1 0 5 
Verdejo-García, A. et al. (2010) 
IGT+D
D 
1 1 1 1 0 
0 1 0 
5 
Verdejo-García, A. et al. (2013) IGT 1 1 1 0 2 0 1 0 6 
Verdejo-Garcia, A. et al. (2007) IGT 1 1 1 1 0 0 1 0 5 
Vuchinich, RE. et al. (1998) DD 0 1 1 0 2 0 1 0 5 
Yan, WS. et al. (2014) IGT 1 1 1 0 1 0 1 0 5 
Zeng, H. et al. (2012) IGT 1 1 1 1 0 0 1 0 5 
Zhang, XL. et al. (2012) IGT 1 1 1 1 0 0 1 0 5 
Zhu, X. et al. (2017) 
IGT+D
D 
1 1 1 1 0 
0 1 0 
5 
Zorlu, N. et al. (2013a) IGT 1 1 0 1 0 0 1 0 4 
Zorlu, N. et al. (2013b) IGT 1 1 1 0 0 0 1 0 4 





Note. * p<.001; DD, Delay Discounting; IGT, Iowa Gambling Task; Newcastle-Ottawa Quality Assessment Scale: Selection; Q1. Is the 
case definition adequate? Q2. Are the cases representative of any population? Q3. Are the controls a community sample or are the 
controls from the same community as the cases would be if had outcome? Q4. Were explicitly report that controls had no history of 
psychiatric disease or substance-related disorder? Comparability; Q1. Were the data analysis controlled for the main variables? 1-yes, 
for the main variable; 2-yes, for the most important variables. Exposure. Q1. Were the structured interviewers blinded to case/control 
status? Q2. Were the same tasks and instruments used to access both cases and controls? Q3. Were the same non-response rate the same 
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